Oncogene - Table of Contents alert Volume 37 Issue 45

Advertisement Difficult ChIP-seq: Solved. Diagenode's cutting-edge ChIPmentation, a unique tagmentation-based technology that incorporates ChIP and library preparation within the same protocol has revolutionized ChIP-seq. This solution is now available for both manual and automated workflows. Ensure high quality data on various histone marks from large cohorts of samples Faster and easier method than ChIP-seq Learn more and see our latest release for histone ChIPmentation TABLE OF CONTENTS Volume 37, Issue 45 In this issue Article Correction Also new AOP Article Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death Charlotte E. Johnson, Elaine A. Dunlop, Sara Seifan, Henry D. McCann, Trevor Hay et al. Oncogene 2018 37 :5913 - 5925; July 06, 2018; 10.1038/s41388-018-0381-2 Abstract | Full Text HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance Rossella Loria, Valentina Laquintana, Giulia Bon, Daniela Trisciuoglio, Roberta Frapolli et al. Oncogene 2018 37 :5926 - 5938; July 06, 2018; 10.1038/s41388-018-0394-x Abstract | Full Text ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer Xiao Guo, Yin Zhang, Anand Mayakonda, Vikas Madan, Ling-Wen Ding et al. Oncogene 2018 37 :5939 - 5951; July 06, 2018; 10.1038/s41388-018-0371-4 Abstract | Full Text Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3–COX2-dependent pathway Ang Li, Ping Chen, Ye Leng & Jiuhong Kang Oncogene 2018 37 :5952 - 5966; July 06, 2018; 10.1038/s41388-018-0379-9 Abstract | Full Text Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma Akira Ooki, Wikum Dinalankara, Luigi Marchionni, Jun-Chieh J. Tsay, Chandra Goparaju et al. Oncogene 2018 37 :5967 - 5981; July 06, 2018; 10.1038/s41388-018-0373-2 Abstract | Full Text ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF Fanyang Kong, Xuan Deng, Xiangyu Kong, Yiqi Du, Lei Li et al. Oncogene 2018 37 :5982 - 5996; July 09, 2018; 10.1038/s41388-018-0387-9 Abstract | Full Text PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer Tingting Yang, Chune Ren, Pengyun Qiao, Xue Han, Li Wang et al. Oncogene 2018 37 :5997 - 6009; July 09, 2018; 10.1038/s41388-018-0386-x Abstract | Full Text Correction Correction: ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF Fanyang Kong, Xuan Deng, Xiangyu Kong, Yiqi Du, Lei Li et al. Oncogene 2018 37 :6010 - 6010; August 14, 2018; 10.1038/s41388-018-0412-z Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from Oncogene click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.